Literature DB >> 15217360

Establishment of a mouse xenograft model for mycosis fungoides.

Sonja Thaler1, Angelika M Burger, Thomas Schulz, Boris Brill, Alexandra Bittner, Patrick A Oberholzer, Reinhard Dummer, Barbara S Schnierle.   

Abstract

Mycosis fungoides (MF) is the most frequent variant of cutaneous T-cell lymphomas (CTCLs). MF primarily involves the skin initially with patches and plaques. In later stages, cutaneous tumors develop and tumor cells may spread to lymph nodes and finally to visceral sites. Here, we describe an animal model for MF in immune-deficient nude mice, using the CTCL cell line MyLa. Subcutaneous transplantation of MyLa cells leads to the formation of cutaneous tumors in 80% of the mice (50/60 total). Spread of tumor cells to visceral sites was detected by immunohistochemistry and polymerase chain reaction (PCR)-based detection of specific T-cell receptor-gamma rearrangement. MyLa cells were found circulating in the blood, lymph nodes, and in blood vessels of heart, kidney, lung, and liver. In lung and liver tissue, tumor cells presented perivascular invasion, but no large secondary tumors developed. The nude mouse model described here will be a valuable test system for new therapeutic approaches for the treatment of MF and opens the unique opportunity to study the disease in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15217360     DOI: 10.1111/j.0906-6705.2004.00201.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  9 in total

1.  Cutaneous Epitheliotropic T-Cell Lymphoma in a Marsh Rice Rat (Oryzomys palustris).

Authors:  Bryan F Taylor; Christine M Bekkevold; J Ignacio Aguirre; Karl Andrutis; Mary K Reinhard
Journal:  Comp Med       Date:  2015-10       Impact factor: 0.982

2.  Role of Dysregulated Cytokine Signaling and Bacterial Triggers in the Pathogenesis of Cutaneous T-Cell Lymphoma.

Authors:  Melania H Fanok; Amy Sun; Laura K Fogli; Vijay Narendran; Miriam Eckstein; Kasthuri Kannan; Igor Dolgalev; Charalampos Lazaris; Adriana Heguy; Mary E Laird; Mark S Sundrud; Cynthia Liu; Jeff Kutok; Rodrigo S Lacruz; Jo-Ann Latkowski; Iannis Aifantis; Niels Ødum; Kenneth B Hymes; Swati Goel; Sergei B Koralov
Journal:  J Invest Dermatol       Date:  2017-11-08       Impact factor: 8.551

3.  A mouse model for the Sézary syndrome.

Authors:  Udo Doebbeling
Journal:  J Exp Clin Cancer Res       Date:  2010-02-11

4.  Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells.

Authors:  Ryan A Wilcox; David A Wada; Steven C Ziesmer; Sherine F Elsawa; Nneka I Comfere; Allan B Dietz; Anne J Novak; Thomas E Witzig; Andrew L Feldman; Mark R Pittelkow; Stephen M Ansell
Journal:  Blood       Date:  2009-08-11       Impact factor: 22.113

5.  Combination of Resminostat with Ruxolitinib Exerts Antitumor Effects in the Chick Embryo Chorioallantoic Membrane Model for Cutaneous T Cell Lymphoma.

Authors:  Fani Karagianni; Christina Piperi; Berta Casar; Dalia de la Fuente-Vivas; Rocío García-Gómez; Kyriaki Lampadaki; Vasiliki Pappa; Evangelia Papadavid
Journal:  Cancers (Basel)       Date:  2022-02-20       Impact factor: 6.639

Review 6.  Understanding Cell Lines, Patient-Derived Xenograft and Genetically Engineered Mouse Models Used to Study Cutaneous T-Cell Lymphoma.

Authors:  Raman Preet Kaur Gill; Jennifer Gantchev; Amelia Martínez Villarreal; Brandon Ramchatesingh; Elena Netchiporouk; Oleg E Akilov; Niels Ødum; Robert Gniadecki; Sergei B Koralov; Ivan V Litvinov
Journal:  Cells       Date:  2022-02-09       Impact factor: 6.600

7.  Validation of AAC-11-Derived Peptide Anti-Tumor Activity in a Single Graft Sézary Patient-Derived Xenograft Mouse Model.

Authors:  Justine Habault; Nicolas Thonnart; Caroline Ram-Wolff; Martine Bagot; Armand Bensussan; Jean-Luc Poyet; Anne Marie-Cardine
Journal:  Cells       Date:  2022-09-20       Impact factor: 7.666

8.  Cytotoxic impact of a perillyl alcohol-temozolomide conjugate, NEO212, on cutaneous T-cell lymphoma in vitro.

Authors:  Catalina Silva-Hirschberg; Hannah Hartman; Samantha Stack; Steve Swenson; Radu O Minea; Michael A Davitz; Thomas C Chen; Axel H Schönthal
Journal:  Ther Adv Med Oncol       Date:  2019-12-06       Impact factor: 8.168

9.  Functional characterization of NPM1-TYK2 fusion oncogene.

Authors:  Sudhakiranmayi Kuravi; Riley W Baker; Muhammad Umair Mushtaq; Irfan Saadi; Tara L Lin; Carolyn J Vivian; Anusha Valluripalli; Sunil Abhyankar; Siddhartha Ganguly; Wei Cui; Kojo S J Elenitoba-Johnson; Danny R Welch; Roy A Jensen; Yogen Saunthararajah; Joseph P McGuirk; Ramesh Balusu
Journal:  NPJ Precis Oncol       Date:  2022-01-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.